( 02256.hk)
市盈率52.77市净率3.64股息率0%上市时间2021-10-13股价13.02港币涨跌幅0.08%成交金额1,412.54万港币换手率0.16%市值88.55亿港币H股市值88.55亿港币总股本6.80亿H股本6.80亿每手股数1,000上市至今年化投资收益率1.28%累计做空占H股比例1.04% (9,455.18万港币2025-12-24)
所属三级行业生物技术 (恒生) 市盈率62.32市净率4.73股息率0.33%恒生:医疗保健业药品及生物科技生物技术
备注 (4): 双击编辑备注
发表讨论

和誉-B(02256) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1孫洪斌Independent Non Executive Director - A/F2021-09-30--
2孫飄揚Independent Non Executive Director2021-09-30--
3王磊Independent Non Executive Director2021-09-30--
4唐豔旻Non Executive Director2021-06-10--
5葉霖Executive Director2021-01-052022-04-28
6XIA Guo Yao GavinNon Executive Director2018-10-222023-06-19
7CHEN ZhuiExecutive Director2018-03-28--
8XU Yao ChangExecutive Director2018-03-28--
9YU Hong PingExecutive Director2018-03-28--